Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900059424> ?p ?o ?g. }
- W2900059424 endingPage "141" @default.
- W2900059424 startingPage "135" @default.
- W2900059424 abstract "Background Since 2004, end-stage renal disease related hyperparathyroidism patients are treated mainly with cinacalcet, which ceased to be subsidized through the Australian Pharmaceutical Benefits Scheme in 2015. We aimed to investigate the impact of these changes on the treatment strategy in the Australian end-stage renal disease population. Methods The following groups were formed according to the date of parathyroidectomy: A, before calcimimetics; B, during the era of calcimimetics; and C, after cinacalcet removal by the Australian Pharmaceutical Benefits Scheme. The primary outcome was time from start of dialysis to parathyroidectomy. Regression analysis was used to examine trends in parathyroidectomy rates. Results Between 1998 and 2016, 195 parathyroidectomies were performed. Median time to referral was 69 (33–123), 67 (31–110) and 44 (23–102) months for groups A, B, and C, respectively (P = .55). Parathyroidectomy rates increased throughout the years (CI 0.09–1.13, R2=0.27, P = .02). A trend toward a dip in parathyroidectomy rates was seen during the era of cinacalcet (P = .08). Median preoperative parathyroid hormone levels increased significantly (842 [418–1,553] versus 1,040 [564–1,810] versus 1,350 [1,037–1,923] pg/mL, for groups A, B, and C, respectively [P < .01]). Conclusion Parathyroidectomy rates seem to vary according to the availability of cinacalcet. This change in treatment strategy is accompanied with increased preoperative parathyroid hormone levels, reflecting delayed surgery and increased disease severity. Since 2004, end-stage renal disease related hyperparathyroidism patients are treated mainly with cinacalcet, which ceased to be subsidized through the Australian Pharmaceutical Benefits Scheme in 2015. We aimed to investigate the impact of these changes on the treatment strategy in the Australian end-stage renal disease population. The following groups were formed according to the date of parathyroidectomy: A, before calcimimetics; B, during the era of calcimimetics; and C, after cinacalcet removal by the Australian Pharmaceutical Benefits Scheme. The primary outcome was time from start of dialysis to parathyroidectomy. Regression analysis was used to examine trends in parathyroidectomy rates. Between 1998 and 2016, 195 parathyroidectomies were performed. Median time to referral was 69 (33–123), 67 (31–110) and 44 (23–102) months for groups A, B, and C, respectively (P = .55). Parathyroidectomy rates increased throughout the years (CI 0.09–1.13, R2=0.27, P = .02). A trend toward a dip in parathyroidectomy rates was seen during the era of cinacalcet (P = .08). Median preoperative parathyroid hormone levels increased significantly (842 [418–1,553] versus 1,040 [564–1,810] versus 1,350 [1,037–1,923] pg/mL, for groups A, B, and C, respectively [P < .01]). Parathyroidectomy rates seem to vary according to the availability of cinacalcet. This change in treatment strategy is accompanied with increased preoperative parathyroid hormone levels, reflecting delayed surgery and increased disease severity." @default.
- W2900059424 created "2018-11-16" @default.
- W2900059424 creator A5016584401 @default.
- W2900059424 creator A5024862063 @default.
- W2900059424 creator A5032098646 @default.
- W2900059424 creator A5041056556 @default.
- W2900059424 creator A5041064321 @default.
- W2900059424 creator A5043698558 @default.
- W2900059424 creator A5053902559 @default.
- W2900059424 creator A5088089336 @default.
- W2900059424 creator A5088412047 @default.
- W2900059424 creator A5026200967 @default.
- W2900059424 date "2019-01-01" @default.
- W2900059424 modified "2023-10-18" @default.
- W2900059424 title "Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics" @default.
- W2900059424 cites W1884456455 @default.
- W2900059424 cites W1967539571 @default.
- W2900059424 cites W1980078060 @default.
- W2900059424 cites W2010449679 @default.
- W2900059424 cites W2031941775 @default.
- W2900059424 cites W2033279041 @default.
- W2900059424 cites W2039397162 @default.
- W2900059424 cites W2044213126 @default.
- W2900059424 cites W2061393936 @default.
- W2900059424 cites W2096893986 @default.
- W2900059424 cites W2109064733 @default.
- W2900059424 cites W2121622805 @default.
- W2900059424 cites W2138829372 @default.
- W2900059424 cites W2143568351 @default.
- W2900059424 cites W2151182745 @default.
- W2900059424 cites W2153781824 @default.
- W2900059424 cites W2210908977 @default.
- W2900059424 cites W2341016265 @default.
- W2900059424 cites W2497171257 @default.
- W2900059424 cites W2571090029 @default.
- W2900059424 cites W2605627159 @default.
- W2900059424 cites W4211140718 @default.
- W2900059424 doi "https://doi.org/10.1016/j.surg.2018.04.092" @default.
- W2900059424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30413324" @default.
- W2900059424 hasPublicationYear "2019" @default.
- W2900059424 type Work @default.
- W2900059424 sameAs 2900059424 @default.
- W2900059424 citedByCount "7" @default.
- W2900059424 countsByYear W29000594242019 @default.
- W2900059424 countsByYear W29000594242020 @default.
- W2900059424 countsByYear W29000594242021 @default.
- W2900059424 crossrefType "journal-article" @default.
- W2900059424 hasAuthorship W2900059424A5016584401 @default.
- W2900059424 hasAuthorship W2900059424A5024862063 @default.
- W2900059424 hasAuthorship W2900059424A5026200967 @default.
- W2900059424 hasAuthorship W2900059424A5032098646 @default.
- W2900059424 hasAuthorship W2900059424A5041056556 @default.
- W2900059424 hasAuthorship W2900059424A5041064321 @default.
- W2900059424 hasAuthorship W2900059424A5043698558 @default.
- W2900059424 hasAuthorship W2900059424A5053902559 @default.
- W2900059424 hasAuthorship W2900059424A5088089336 @default.
- W2900059424 hasAuthorship W2900059424A5088412047 @default.
- W2900059424 hasBestOaLocation W29000594242 @default.
- W2900059424 hasConcept C126322002 @default.
- W2900059424 hasConcept C126894567 @default.
- W2900059424 hasConcept C141071460 @default.
- W2900059424 hasConcept C2775945674 @default.
- W2900059424 hasConcept C2777645128 @default.
- W2900059424 hasConcept C2778653478 @default.
- W2900059424 hasConcept C2778838027 @default.
- W2900059424 hasConcept C2779053571 @default.
- W2900059424 hasConcept C2780534505 @default.
- W2900059424 hasConcept C2781208988 @default.
- W2900059424 hasConcept C2908647359 @default.
- W2900059424 hasConcept C519063684 @default.
- W2900059424 hasConcept C71924100 @default.
- W2900059424 hasConcept C99454951 @default.
- W2900059424 hasConceptScore W2900059424C126322002 @default.
- W2900059424 hasConceptScore W2900059424C126894567 @default.
- W2900059424 hasConceptScore W2900059424C141071460 @default.
- W2900059424 hasConceptScore W2900059424C2775945674 @default.
- W2900059424 hasConceptScore W2900059424C2777645128 @default.
- W2900059424 hasConceptScore W2900059424C2778653478 @default.
- W2900059424 hasConceptScore W2900059424C2778838027 @default.
- W2900059424 hasConceptScore W2900059424C2779053571 @default.
- W2900059424 hasConceptScore W2900059424C2780534505 @default.
- W2900059424 hasConceptScore W2900059424C2781208988 @default.
- W2900059424 hasConceptScore W2900059424C2908647359 @default.
- W2900059424 hasConceptScore W2900059424C519063684 @default.
- W2900059424 hasConceptScore W2900059424C71924100 @default.
- W2900059424 hasConceptScore W2900059424C99454951 @default.
- W2900059424 hasIssue "1" @default.
- W2900059424 hasLocation W29000594241 @default.
- W2900059424 hasLocation W29000594242 @default.
- W2900059424 hasLocation W29000594243 @default.
- W2900059424 hasLocation W29000594244 @default.
- W2900059424 hasOpenAccess W2900059424 @default.
- W2900059424 hasPrimaryLocation W29000594241 @default.
- W2900059424 hasRelatedWork W1966238058 @default.
- W2900059424 hasRelatedWork W1967923169 @default.
- W2900059424 hasRelatedWork W2023088314 @default.
- W2900059424 hasRelatedWork W2105314539 @default.
- W2900059424 hasRelatedWork W2133709292 @default.